Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines

Abstract

Hanifah Yusuf, Denny Satria, Suryawati Suryawati, Marhami Fahriani

Doxorubicin (DOXO) is an anticancer that is often used clinically which induces cardiotoxicity in the patient. Therefore, finding a new compound that acts as co-chemotherapy is a current challenge. Eurycomanone (EURY) isolated from Eurycoma longifolia Jack have been shown to have anticancer activity in several studies. This study aimed to observe the effect of EURY, DOXO, and its combination on the cell cycle of T47D and MCF-7 breast cancer cell lines. Anticancer activities of EURY and DOXO were examined by MTT colorimetry assay. The effect of combination was analyzed by the Combination Index (CI) method using Compusyn software. The apoptotic activity was analyzed using flow cytometry. To determine CI, a fixed concentration ratio between EURY and DOXO was used from the IC50 value at concentrations (1/2; 1/4; 1/8; 1/16 of IC50). We found that EURY had IC50 values at 0.377μg/mL on T47D and 4.7μg/mL on MCF-7 cells, while DOXO had IC50 values 1.845μg/mL on T47D and 5.074μg/mL on MCF-7cells. The optimal combination of EURY and DOXO on T47D was at 1/16 IC50 EURY – 1/6 IC50 DOXO with CI of 0.3442, whereas on MCF-7 was at 1/16 IC50 of EURY – ½ IC50 DOXO with CI 0.0221. Apoptosis was significantly higher in MCF-7 cells treated with EURY alone than DOXO alone with p<0.001. On T47D cells, DOXO alone resulted in more cell death than EURY alone, although not statistically significant. Cell death was higher in both cancer lines when EURY and DOXO were combined compared to DOXO alone with p<0.05 in both comparisons.

How to Cite this Article
Pubmed Style

Yusuf H, Satria D, Suryawati S, Fahriani M. Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. SRP. 2020; 11(10): 335-341.
doi:10.31838/srp.2020.10.55

Web Style

Yusuf H, Satria D, Suryawati S, Fahriani M. Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. http://www.sysrevpharm.org/?mno=27468 [Access: March 29, 2021]. doi:10.31838/srp.2020.10.55

AMA (American Medical Association) Style

Yusuf H, Satria D, Suryawati S, Fahriani M. Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. SRP. 2020; 11(10): 335-341. doi:10.31838/srp.2020.10.55



Vancouver/ICMJE Style

Yusuf H, Satria D, Suryawati S, Fahriani M. Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. SRP. (2020), [cited March 29, 2021]; 11(10): 335-341. doi:10.31838/srp.2020.10.55



Harvard Style

Yusuf, H., Satria, . D., Suryawati, . S. & Fahriani, . M. (2020) Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. SRP, 11 (10), 335-341. doi:10.31838/srp.2020.10.55



Turabian Style

Yusuf, Hanifah, Denny Satria, Suryawati Suryawati, and Marhami Fahriani. 2020. Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. Systematic Reviews in Pharmacy, 11 (10), 335-341. doi:10.31838/srp.2020.10.55



Chicago Style

Yusuf, Hanifah, Denny Satria, Suryawati Suryawati, and Marhami Fahriani. "Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines." Systematic Reviews in Pharmacy 11 (2020), 335-341. doi:10.31838/srp.2020.10.55



MLA (The Modern Language Association) Style

Yusuf, Hanifah, Denny Satria, Suryawati Suryawati, and Marhami Fahriani. "Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines." Systematic Reviews in Pharmacy 11.10 (2020), 335-341. Print. doi:10.31838/srp.2020.10.55



APA (American Psychological Association) Style

Yusuf, H., Satria, . D., Suryawati, . S. & Fahriani, . M. (2020) Combination Therapy of Eurycomanone and Doxorubicin As Anticancer on T47D and MCF-7 Cell Lines. Systematic Reviews in Pharmacy, 11 (10), 335-341. doi:10.31838/srp.2020.10.55

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3